New Research Centre to be developed in Lavale
Serum Institute and Symbiosis International University has signed up an MoU to set up an early research centre for vaccines and biologicals in its University […]
News
Union Government incentives local API production
Union government has earmarked ₹ 6,940 crore scheme to provide a boost to Active Pharmaceutical Ingredients (API) sector. In order to reduce dependent on imports, […]
DRL forays into health drink segment
Dr Reddy’s Laboratories Ltd has forayed into the nutrition segment with the launch of ‘Celevida’ in India. The first-of-its-kind health drink has been proven to […]
Cadila Pharma receives GLPC certification for its Dholka facility
Cadila Pharma has received the Good Laboratory Practices Certification (GLP) from National Good Laboratory Practice compliance Monitoring Authority (NGCMA), Department of Science and Technology, Government […]
Everest Organics sets up R&D lab in Aroor, Hyderabad
Everest Organics Ltd has set up a research development centre in Aroor in Hyderabad in Telangana. The new centre will help the company to offer […]
Hetero Labs launches generic version of Lapatinib
Hetero Labs has launched a generic version of Lapatinib (250 mg) tablets in India. The product is marketed and distributed under the brand name ‘HERTAB’ […]
Hetero Labs acquire Tarbis Farma SLU
Hetero Labs Ltd has acquired Tarbis Farma, S.L.U., a group company of Grupo Ferrer Internacional, SA through its subsidiary Amarox Ltd. The company Tarbis Farma […]
Sun Pharma acquires Pola Pharma-Japan
Sun Pharma has completed acquisition of Pola Pharma – a Japanese pharma company to strengthen its presence in dermatology segment across the globe. The company […]
Lupin signs agreement with AbbVie for MALT1 inhibitor programme
Lupin has tied up with – AbbVie – a global biopharmaceutical company to develop new drugs. AbbVie has signed an agreement to get license rights […]
Alembic raises ₹ 3500 million by private placement
Alembic Pharmaceuticals has raised ₹3500 million through allotment of non-convertible debentures (NCDs) on private placement basis. The NCD committee of Alembic Pharmaceuticals Ltd has allotted […]